1. Introduction
===============

Snake venoms have been recognized as an extensible source of bioactive peptides with potential biotechnological applications in medicine \[[@B1-toxins-05-00327]\]. Due to their high degree of target specificity, venom toxins have been increasingly used as lead compounds in the development of drug prototypes \[[@B2-toxins-05-00327]\]. One of the most successful examples has been Captopril^®^, an antihypertensive drug based on a bradykinin-potentiating peptide (BPP) isolated from Brazilian *Bothropoides* (*Bothrops*) *jararaca* venom \[[@B3-toxins-05-00327],[@B4-toxins-05-00327]\]. The BPP family comprises a class of angiotensin-I converting enzyme (ACE) inhibitors with different lengths (5 to 14 amino acid residues) found in venoms produced by snakes, scorpions, spiders and amphibians \[[@B5-toxins-05-00327]\]. Generally, BPPs have a conserved *N*-terminal pyroglutamate residue (Z) and two consecutive proline residues at the *C*-terminal region \[[@B6-toxins-05-00327],[@B7-toxins-05-00327]\]. This work describes the identification and characterization of a new BPP from Amazon *Bothrops atrox* snake venom.

2. Materials and Methods
========================

2.1. Venom
----------

*Bothrops atrox* specimens collected around the city of Porto Velho, State of Rondônia, Brazil were kept at Fiocruz Rondônia bioterium in order to be used for venom production under authorization emitted by IBAMA (licence number 27131-1) and CGEN (licence number 010627/2011-1). The crude venom was dehydrated and stored at a temperature of −20 °C in the Amazon Venom Bank at CEBio.

2.2. Peptide Isolation
----------------------

The purification of BPP-BAX12 was performed using 50 mg of crude venom, which was divided fractioned into two fractions on a size exclusion chromatography column using a Superdex peptide-10/300GL column (GE Healthcare) equilibrated with 50 mmol/L Tris-HCl buffer (pH 7.4) and carried out at a flow rate of 0.5 mL/min. The second fraction produced, which was related to peptides, was re-chromatographed under the same conditions resulting in eight fractions. The fourth fraction (37--43 min) was then lyophilized and stored for MS/MS analysis.

2.3. MS Parameters and Data Acquisition
---------------------------------------

ESI-MS spectra were obtained in positive ion mode on a hybrid Qq-*oa*TOF mass spectrometer---Xevo G2 QTof MS (Waters, Manchester, UK). Typical ESI-MS conditions were done in positive mode as follow: source temperature 80 °C, capillary voltage 2.8 kV, and cone voltage 35 V, resolution mode with an analogic-to-digital converter (ADC) mode, detector at 2825 V previously adjusted with leukine enkephalin (Leu-Enk) solution at 2 ng/μL. The instrument was automatically calibrated with sodium iodide solution through IntelliStart, integral part of MassLynx 4.1v acquisition software (Waters, Manchester, UK). Samples were re-suspended in a vial with a solution containing equal parts of water and methanol with 0.1% of formic acid for each sample to proceed ESI(+)-MS analysis. These solutions were then injected at a flow rate of 500 nL/min, using the fluid system installed in the Xevo G2 QTof MS panel controlled by the IntelliStart software and MS tune page. All MS spectra were acquired over the *m/z* 50--2000. MS/MS acquisition was performed using the quadrupole with high discrimination for each *m/z* of interest. The collision energy was applied to the selected precursor ion and a collision-induced dissociation (CID) at the T-Wave collision cell filled with argon gas was used. 25 eV was applied to the collision cell depending on the precursor ion dissociation characteristics.

2.4. MS/MS Analysis
-------------------

The MS/MS spectra were de-convoluted using MaxEnt 3 software (Waters, Manchester, UK) and then transferred to a PepSeq application into BioLynx software package and a Microsoft Excel file with data up to 120 counts in order to proceed with manual evaluation. The identification of the most common diagnostic peptide fragment ions (a^+^, b^+^, y^+^-type) currently observed in low energy collisions and immonium ions for *de novo* peptide sequencing were performed manually using the program Microsoft Excel with data of monoisotopic mass of common and less common amino acid residues, terminal groups and post-translational modifications for the use in mass spectrometry calculated using the following atomic masses of the most abundant isotope of the elements: C = 12.0000000, H = 1.0078250, N = 14.0030740, O = 15.9949146, F = 18.9984033, P = 30.9737634, S = 31.9720718, Cl = 34.9688527, Br = 78.9183361. Fragments with intensity higher than 200 counts and mass accuracy between 0 and ± 17 ppm, according to the equation 1, was used for *de novo* peptide sequencing.

Mass accuracy (ppm) = 1,000,000 × (theoretical mass − measured mass)/theoretical mass

MassSeq application and *de novo* sequencing analysis and interpretation tool of the BioLynx software package was used in order to confirm manual analysis using the following peptide sequencing parameters: *m*/*z* tolerance of 0.03 for peptide and fragments and intensity threshold of 0.003%.

3. Results and Discussion
=========================

The mass spectrometric analysis of the fourth chromatographic fraction reveals a high intensity doubly protonated ion peak at *m/z* 692.8732 \[M + 2H\]^2+^. The ion was selected and submitted to collision-induced dissociation (CID) with argon gas resulting in a mass spectrum ([Figure 1](#toxins-05-00327-f001){ref-type="fig"}), which was submitted to the identification of a^+^, b^+^, and y^+^-type diagnostic fragments and immonium ions for *de novo* peptide sequence ([Table 1](#toxins-05-00327-t001){ref-type="table"}, [Table 2](#toxins-05-00327-t002){ref-type="table"}) \[[@B8-toxins-05-00327]\]. The analysis revealed a 12 residue proline-rich peptide (Pyr-Lys-Trp-Pro-Arg-Pro-Gly-Pro-Glu-Ile/Leu-Pro-Pro) with a conserved consecutive two proline residues at the *C*-terminal region, a characteristic of the BPP family of ACE inhibitors \[[@B6-toxins-05-00327],[@B7-toxins-05-00327]\], and a *N*-terminal pyroglutamic acid (Pyr), which could be derived from glutamine or glutamic acid residues, as observed in other currently described snake venom BPPs from Bothrops species. The measured peptide monoisotopic mass (1384.7386) and theoretical (1384.7378) was very similar, showing a mass accuracy of 0.6 ppm, which was also observed for the identified diagnostic fragment ions ([Table 1](#toxins-05-00327-t001){ref-type="table"}, [Table 2](#toxins-05-00327-t002){ref-type="table"}), thus showing the high precision of the analysis. Sequence similarity showed that the peptide is homologous to other BPP described for *B. moojeni* venom \[[@B6-toxins-05-00327]\] and similar to others from *Bothrops neuwiedi* \[[@B1-toxins-05-00327],[@B9-toxins-05-00327]\], *B. leucurus*, *B. erythromelas*, *B. alternatus* \[[@B10-toxins-05-00327]\], *B. insularis* \[[@B1-toxins-05-00327],[@B10-toxins-05-00327],[@B11-toxins-05-00327]\], *B. jararaca* \[[@B12-toxins-05-00327],[@B13-toxins-05-00327]\], *B. jararacussu* \[[@B1-toxins-05-00327],[@B10-toxins-05-00327],[@B14-toxins-05-00327]\], *B. cotiara* \[[@B13-toxins-05-00327]\], and *B. fonsecai* \[[@B13-toxins-05-00327]\] ([Table 3](#toxins-05-00327-t003){ref-type="table"}). This peptide was named as Bradykinin-potentiating peptide BAX12.

![Collision-induced dissociation spectra of BPP-BAX12. The deduced sequence is shown at the top of the MS/MS profile. The inset shows the assigned peptide sequence.](toxins-05-00327-g001){#toxins-05-00327-f001}

toxins-05-00327-t001_Table 1

###### 

Diagnostic peptide fragments (b, a and y-type ions) obtained by collision-induced dissociation with argon gas used for *de novo* peptide sequencing of BPP-BAX12.

  Aminoacid Residue   Fragment    Theoretical (*m*/*z*)   Measured (*m*/*z*)   Intensity (counts)   Accuracy (ppm)   Fragment    Theoretical (*m*/*z*)   Measured (*m*/*z*)   Intensity (counts)   Accuracy (ppm)   Fragment    Theoretical (*m*/*z*)   Measured (*m*/*z*)   Intensity (counts)   Accuracy (ppm)
  ------------------- ----------- ----------------------- -------------------- -------------------- ---------------- ----------- ----------------------- -------------------- -------------------- ---------------- ----------- ----------------------- -------------------- -------------------- ----------------
  Z                   b~1~        112.0399                \-                   \-                   \-               a~1~        84.0688                 \-                   \-                   \-               y~12~       1384.7377               1384.7548            1.6 × 10^2^          11.7
  K                   b~2~\*      223.1083                223.1082             2.7 × 10^3^          0.2              a~2~ \*     195.1134                195.1134             4.0 × 10^3^          −0.2             y~11~       1273.7057               1273.6853            1.6 × 10^2^          16.0
  b~2~                240.1348    240.1348                5.2 × 10^4^          0.1                  a~2~             212.1399    212.1405                6.1 × 10^3^          −2.9                 y~11~\*          1256.6792   \-                      \-                   \-                   
  W                   b~3~        426.2141                426.2140             1.2 × 10^5^          0.3              a~3~        398.2192                398.2188             3.3 × 10^4^          1.0              y~10~       1145.6107               1145.6276            2.0 × 10^5^          14.8
  P                   b~4~        523.2669                523.2667             2.9 × 10^4^          0.4              a~4~        495.2720                495.2684             3.1 × 10^4^          7.2              y~9~        959.5314                959.5308             9.9 × 10^4^          0.6
  R                   b~5~\*      662.3415                622.3417             7.0 × 10^3^          −0.4             a~5~\*      634.3466                634.3317             3.7 × 10^4^          23.4             y~8~        862.4786                862.4774             1.3 × 10^4^          1.4
  b~5~                679.3680    679.3676                9.3 × 10^4^          0.6                  a~5~             651.3731    651.3705                1.2 × 10^4^          4.0                  y~8~\*           845.4520    845.4680                6.0 × 10^3^          −18.9                
  P                   b~6~        776.4208                776.4209             1.7 × 10^4^          −0.2             a~6~        748.4259                748.4175             3.0 × 10^4^          11.2             y~7~        706.3775                706.3775             2.3 × 10^4^          0.0
  G                   b~7~        833.4422                833.4417             1.9 × 10^4^          −0.6             a~7~        805.4473                805.4473             1.8 × 10^3^          0.0              y~6~        609.3248                609.3238             3.6 × 10^2^          1.6
  P                   b~8~        930.4950                930.4941             8.4 × 10^3^          1.0              a~8~        902.5001                902.5016             1.2 × 10^3^          −1.7             y~5~        552.3033                552.3032             4.8 × 10^3^          0.2
  E                   b~9~\#      1041.5273               1041.5265            2.0 × 10^3^          0.8              a~9~\#      1013.5321               1013.5197            4.4 × 10^2^          12.2             y~4~        455.2505                455.2492             3.7 × 10^2^          2.8
  b~9~                1059.5376   1059.5365               5.0 × 10^5^          1.0                  a~9~             1031.5427   1031.5427               4.9 × 10^4^          0.0                  y~4~\#           437.2399    437.2360                6.3 × 10^3^          9.0                  
  I/L                 b~10~       1172.6206               1172.6207            6.6 × 10^5^          −0.1             a~10~       1144.6257               1144.6255            2.1 × 10^5^          0.2              y~3~        326.2081                326.2079             4.9 × 10^4^          0.7
  P                   b~11~       1269.6734               \-                   \-                   \-               a~11~       1241.6785               \-                   \-                   \-               y~2~        213.1241                213.1241             3.8 × 10^6^          −0.1
  P                   b~12~       1366.7261               \-                   \-                   \-               a~12~       1338.7312               \-                   \-                   \-               y~1~        116.0712                116.0713             1.6 × 10^5^          −1.2

Immonium ions detected Theoretical *m*/*z*, measured *m*/*z* (accuracy in ppm): Z 84.04496, 84.0446 \[4.3\]; K(--NH~3~) 84.08129, 84.08144 \[−1.3\]; R(--NH~3~) 112.08746, 112.0877 \[−2.2\]; W 159.09220, 159.0922 \[0.0\]; P 70.06568, 70.0659 \[3.1\]; I/L 86.09698, 86.0970 \[−0.2\]. **\*** Loss of a neutral ammonia (NH~3~) molecule from K or R side chains. **\#** loss of a neutral H~2~O molecule from E side chain.

toxins-05-00327-t002_Table 2

###### 

Diagnostic internal fragments (b and a-type ions) ions obtained by collision-induced dissociation with argon gas used for *de novo* peptide sequencing of BPP-BAX12.

  Fragments               b-Type ions   a-Type ions                                                               
  ----------------------- ------------- ------------- ------------- ------- ----------- ----------- ------------- -------
  KWPRPGP                 819.4629      \-            \-            \-      791.46799   \-          \-            \-
  KWPRPGP \*              802.4364      802.4401      2.3 × 10^2^   −4.6    774.44149   \-          \-            \-
  KWPRPG                  722.4102      \-            \-            \-      694.41529   \-          \-            \-
  KWPRPG \*               705.3836      705.3939      8.2 × 10^2^   −14.6   677.38869   677.3793    1.0 × 10^3^   13.9
  KWPRP                   665.3887      \-            \-            \-      637.39379   \-          \-            \-
  KWPRP \*                648.3622      \-            \-            \-      620.36729   \-          \-            \-
  KWPR                    568.3359      \-            \-            \-      540.34099   540.3436    1.7 × 10^2^   −4.8
  KWPR \*                 551.3094      \-            \-            \-      523.31449   \-          \-            \-
  KWP                     412.2349      412.2426      4.9 × 10^2^   −18.7   384.23999   \-          \-            \-
  KWP \*                  395.2083      \-            \-            \-      367.21339   \-          \-            \-
  KW                      315.1821      315.1797      2.2 × 10^2^   7.6     287.18719   \-          \-            \-
  KW \*                   298.1556      298.1567      6.3 × 10^2^   −3.7    270.16069   270.1608    1.9 × 10^3^   −0.4
  WPRPGPEIP               1030.5474     1030.5469     1.0 × 10^3^   0.5     1002.5525   1002.5590   1.3 × 10^2^   −6.5
  WPRPGPEIP \*            1013.5209     1013.5197     4.4 × 10^2^   1.1     985.5259    \-          \-            \-
  WPRPGPEI                933.4946      933.4941      2.8 × 10^4^   0.5     905.4997    905.4992    5.0 × 10^3^   0.5
  WPRPGPEI \*             916.4681      916.4681      2.5 × 10^3^   0.0     888.4731    888.4796    9.8 × 10^2^   −7.3
  WPRPGPE                 820.4106      820.4102      1.5 × 10^4^   0.5     792.4157    792.4160    3.4 × 10^3^   −0.4
  WPRPGPE \*              803.3841      803.3862      1.5 × 10^3^   −2.7    775.3891    775.3857    6.3 × 10^2^   4.4
  WPRPGP                  691.3680      691.3715      7.7 × 10^2^   −5.1    663.3731    \-          \-            \-
  WPRPGP \*               674.3415      \-            \-            \-      646.3465    646.3524    3.0 × 10^2^   −9.1
  WPRPG                   594.3152      594.3206      2.4 × 10^3^   −9.1    566.3203    \-          \-            \-
  WPRPG \*                577.2887      577.2831      1.9 × 10^2^   9.6     549.2937    \-          \-            \-
  WPRP                    537.2938      \-            \-            \-      509.2989    \-          \-            \-
  WPRP \*                 520.2673      \-            \-            \-      492.2723    492.2757    1.6 × 10^2^   −6.8
  WPR                     440.2410      440.2399      4.6 × 10^3^   2.5     412.2461    \-          \-            \-
  WPR \*                  423.2145      423.2138      2.2 × 10^3^   1.5     395.2195    395.2174    8.6 × 10^2^   5.4
  WP                      284.1399      \-            \-            \-      256.1450    256.1468    5.5 × 10^2^   −7.1
  PRPGPEIP                844.4681      844.4672      7.8 × 10^3^   1.1     816.4732    \-          \-            \-
  PRPGPEIP \*             827.4416      827.4381      1.6 × 10^2^   4.2     799.4466    \-          \-            \-
  PRPGPEI/RPGPEIP         747.4153      747.4150      5.1 × 10^4^   0.4     719.4204    719.4196    1.3 × 10^4^   1.1
  PRPGPEI \*/RPGPEIP \*   730.3888      730.3976      4.4 × 10^3^   −12.1   702.3938    702.4028    1.4 × 10^3^   −12.7
  PRPGPE                  634.3313      634.3317      3.7 × 10^4^   −0.6    606.3364    606.3362    1.1 × 10^4^   0.3
  PRPGPE \*               617.3048      617.3059      3.4 × 10^3^   −1.9    589.3098    589.3193    2.2 × 10^3^   −16.0
  PRPGP                   505.2887      505.2886      1.6 × 10^3^   0.2     477.2938    477.295     3.9 × 10^2^   −2.5
  PRPGP \*                488.2622      488.2668      1.4 × 10^2^   −9.5    460.2672    \-          \-            \-
  PRPG/RPGP               408.2359      408.2354      2.2 × 10^3^   1.2     380.2410    380.2346    5.6 × 10^2^   16.8
  PRPG \*/RPGP \*         391.2094      \-            \-            \-      363.2144    \-          \-            \-
  PRP                     351.2145      351.2112      2.1 × 10^3^   9.4     323.2196    \-          \-            \-
  PRP \*                  334.1880      334.1869      6.7 × 10^2^   3.2     306.1930    \-          \-            \-
  PR/RP                   254.1617      254.1616      2.2 × 10^4^   0.4     226.1668    \-          \-            \-
  PR/RP \*                237.1352      237.136       2.8 × 10^3^   −3.6    209.1402    209.1388    4.1 × 10^2^   6.9
  RPGPEI                  650.3626      650.3616      4.7 × 10^3^   1.5     622.3677    \-          \-            \-
  RPGPEI \*               633.3361      \-            \-            \-      605.3411    605.3397    1.2 × 10^3^   2.4
  RPGPE                   537.2785      537.2814      2.9 × 10^3^   −5.4    509.2836    509.2862    2.2 × 10^3^   −5.1
  RPGPE \*                520.2520      520.2515      9.3 × 10^2^   0.9     492.2570    492.2552    6.2 × 10^2^   3.7
  RPG                     311.1832      \-            \-            \-      283.1883    \-          \-            \-
  RPG \*                  294.1567      294.1559      2.4 × 10^2^   2.6     266.1617    \-          \-            \-
  IP                      211.1446      211.1445      3.1 × 10^3^   0.5     183.14969   183.1503    1.2 × 10^3^   −3.3

**\*** Loss of a neutral ammonia (NH~3~) molecule from K or R side chains.

toxins-05-00327-t003_Table 3

###### 

Sequence alignment between BPP-BAX12 and Pyroglutamate peptides/Bradykinin-potentiating (BPPs) sequences from others Bothrops species.

  BPP name                                                                                                                              Sequence        Bothrops specie                                                                                                                                                  Reference
  ------------------------------------------------------------------------------------------------------------------------------------- --------------- ---------------------------------------------------------------------------------------------------------------------------------------------------------------- ---------------------------------------------------------------------------------------------------------------------------------------------
  BPP-BAX12                                                                                                                             ZKWPRPGPEIPP    *Bothrops atrox*                                                                                                                                                 this work
  \-                                                                                                                                    ZKWPRPGPEIPP    *B. moojeni*                                                                                                                                                     \[[@B6-toxins-05-00327]\]
  \-                                                                                                                                    ZNWPRPGPEIPP    *B. moojeni*                                                                                                                                                     \[[@B6-toxins-05-00327]\]
  BPP3_BOTNU, BPP13_BOTMO, BPP13_BOTLC, BPP13_BOTER, BPP13_BOTAL, BNP_BOTIN, BNP2_BOTJA, BNP1_BOTJA, Q8QG90_BOTIN, BNP_BOTJR **^\#^**   ZGGWPRPGPEIPP   *B. neuwiedi*, *B. moojeni*, *B. leucurus*, *B. erythromelas*, *B. alternatus*, *B. insularis*, *B. jararaca*, *B. jararaca*, *B. insularis*, *B. jararacussu*   \[[@B1-toxins-05-00327],[@B9-toxins-05-00327],[@B10-toxins-05-00327],[@B11-toxins-05-00327],[@B12-toxins-05-00327],[@B13-toxins-05-00327]\]
  BPP-13a                                                                                                                               ZGGWPRPGPEIPP   *B. cotiara*, *B. fonsecai*                                                                                                                                      \[[@B14-toxins-05-00327]\]
  BPP-13b                                                                                                                               ZGGLPRPGPEIPP   *B. cotiara*, *B. fonsecai*                                                                                                                                      \[[@B14-toxins-05-00327]\]

**^\#^** Entry name from UniProtKB.

4. Conclusions
==============

Recent papers on venomics \[[@B15-toxins-05-00327]\], proteome \[[@B16-toxins-05-00327]\] and transcriptome \[[@B17-toxins-05-00327]\] of *B. atrox* snake have shown an absence of BPP structures. However, only a single cluster that matched a 5\' untranslated region of a BPP mRNA from *B. jararacussu* snake was found \[[@B11-toxins-05-00327]\]. The BAX12 is the first peptide belonging to the BPP family of ACE inhibitor described for *Bothrops atrox*. The complete homology between BPP-BAX12 from *Bothrops moojeni* \[[@B6-toxins-05-00327]\] and others BPPs could provide interesting information regarding the evolutionary relationship between Bothrops snake species.
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